Market Currents
Pfizer's (PFE) aggressive tax-avoidance schemes are under scrutiny from the SEC, which has sent...
-
Sunday, October 7, 2012, 5:27 AM ETPfizer's (PFE) aggressive tax-avoidance schemes are under scrutiny from the SEC, which has sent the phama giant a letter asking how it was able to earn record profit abroad and losses domestically despite generating 40% of its sales in the U.S. Pfizer's trick is to park its cash in low-tax jurisdictions.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 7 comments: